Page last updated: 2024-08-21

cyclopentane and Parkinsonian Disorders

cyclopentane has been researched along with Parkinsonian Disorders in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-199013 (76.47)18.7374
1990's0 (0.00)18.2507
2000's3 (17.65)29.6817
2010's1 (5.88)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amalric, M; Brotchie, JM; Johnston, TH; Lopez, S; Neuville, P; Schann, S; Turle-Lorenzo, N1
BOOIJ, J1
DUNHAM, WF; EDWARDS, CH1
KOWALEWSKI, K; MAHAUX, J1
Alam, M; Danysz, W; Dekundy, A; Schmidt, WJ1
Amalric, M; Jouve, L; Kerkerian-Legoff, L; Lopez, S; Salin, P; Turle-Lorenzo, N1
BEHREND, RC1
SANYAL, RK1
LEIGH, D; SCHWAB, RS2
DIERCKS, AL1
PAKESCH, EF1
JORDAN, J; UIBERALL, E1
WINTHER, K1
Konieczny, J; Kuter, K; Ossowska, K; Pilc, A; Wardas, J1
COBB, CT; LEIGH, D; SCHWAB, RS1
SCHWAB, RS; TILLMANN, WR1

Other Studies

17 other study(ies) available for cyclopentane and Parkinsonian Disorders

ArticleYear
Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
    Neuropharmacology, 2008, Volume: 55, Issue:4

    Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Haloperidol; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Wistar; Reaction Time; Receptors, Adenosine A2; Receptors, Metabotropic Glutamate; Tricarboxylic Acids; Xanthines

2008
The treatment of Parkinson's syndrome with parpanite.
    Nederlands tijdschrift voor geneeskunde, 1948, Apr-03, Volume: 92, Issue:14

    Topics: Cyclopentanes; Parkinsonian Disorders

1948
Parkinsonism treated with parpanit.
    Lancet (London, England), 1948, Nov-06, Volume: 2, Issue:6532

    Topics: Cyclopentanes; Parkinsonian Disorders

1948
Study of the influence of the ethylaminoethyl ester of phenyl-cyclopentane-carboxylic acid (parpanit) on the elevation of the combustion of parkinson patients.
    Schweizerische medizinische Wochenschrift, 1948, Oct-16, Volume: 78, Issue:41

    Topics: Cyclopentanes; Parkinsonian Disorders

1948
Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
    Toxicology and applied pharmacology, 2009, Oct-15, Volume: 240, Issue:2

    Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Hypokinesia; Idazoxan; Male; Motor Activity; Muscle Rigidity; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Adrenergic, alpha-2; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Rotenone; Serotonin; Substantia Nigra; Time Factors

2009
Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity.
    Neurobiology of disease, 2012, Volume: 46, Issue:1

    Topics: Animals; Cyclopentanes; Disease Models, Animal; Excitatory Amino Acid Agonists; Male; Neural Pathways; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Stereoisomerism; Substantia Nigra; Subthalamic Nucleus; Tricarboxylic Acids

2012
[Parpanit therapy of extrapyramidal disorders].
    Munchener medizinische Wochenschrift (1950), 1951, Jan-05, Volume: 93, Issue:1

    Topics: Basal Ganglia Diseases; Cyclopentanes; Parkinsonian Disorders

1951
A case of Parkinson's disease treated with parpanit.
    The Indian medical gazette, 1949, Volume: 84, Issue:8

    Topics: Cyclopentanes; Parkinson Disease; Parkinsonian Disorders

1949
[Parpanit in the treatment of Parkinson disease (transl)].
    Prensa medica argentina, 1949, Dec-09, Volume: 36, Issue:49

    Topics: Cyclopentanes; Parkinson Disease; Parkinsonian Disorders

1949
[Experience with therapeutic use of parpanit].
    Nederlands tijdschrift voor geneeskunde, 1950, May-06, Volume: 94, Issue:18

    Topics: Cyclopentanes; Parkinsonian Disorders

1950
[Treatment of extrapyramidal motor disturbances].
    Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete, 1950, Volume: 31, Issue:6

    Topics: Cyclopentanes; Movement; Paralysis; Parkinsonian Disorders

1950
[Modern drugs in the treatment of parkinsonism and similar diseases].
    Revista medica de Chile, 1950, Volume: 78, Issue:7

    Topics: Cyclopentanes; Mephenesin; Paralysis; Parkinsonian Disorders; Phenothiazines

1950
[Treatment of paralysis agitans with some new preparations: parpanit, diparcol, and phenergan].
    Ugeskrift for laeger, 1950, May-25, Volume: 112, Issue:21

    Topics: Cyclopentanes; Histamine; Parkinson Disease; Parkinsonian Disorders; Phenothiazines; Promethazine

1950
The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats.
    Neuroscience, 2007, Mar-16, Volume: 145, Issue:2

    Topics: Animals; Corpus Striatum; Cyclopentanes; Dopamine Antagonists; Dose-Response Relationship, Drug; Enkephalins; Excitatory Amino Acid Agonists; Gene Expression Regulation; Glutamic Acid; Haloperidol; Male; Neural Pathways; Opioid Peptides; Parkinsonian Disorders; Protein Precursors; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; RNA, Messenger; Substantia Nigra; Synaptic Transmission; Tricarboxylic Acids; Up-Regulation

2007
Parpanit in the treatment of Parkinson's disease.
    Journal of the American Medical Association, 1949, Mar-05, Volume: 139, Issue:10

    Topics: Cyclopentanes; Humans; Parkinson Disease; Parkinsonian Disorders

1949
Treatment of Parkinson's disease with parpanit; a preliminary report.
    Transactions of the American Neurological Association, 1948, Volume: 73, Issue:73 Annual

    Topics: Cyclopentanes; Humans; Parkinson Disease; Parkinsonian Disorders

1948
Artane in the treatment of Parkinson's disease; a report of its effectiveness alone and in combination with benadryl and parpanit.
    The New England journal of medicine, 1949, Sep-29, Volume: 241, Issue:13

    Topics: Cyclopentanes; Diphenhydramine; Parkinson Disease; Parkinsonian Disorders; Trihexyphenidyl

1949